• 11

• September

• 2023

Revance Therapeutics grows Nashville office, therapeutic pipeline

LEARN MORE

• 01

• September

• 2023

Daxxify: Everything to Know About the Longer-Lasting Botox Alternative

LEARN MORE

• 23

• August

• 2023

Navigating Daxxify’s Potential in the Aesthetic Landscape

LEARN MORE

• 22

• August

• 2023

Revance to Host Investor Day on September 19, 2023

LEARN MORE

• 21

• August

• 2023

Every Injectable in Allure Editors’ Faces Right Now

LEARN MORE

• 19

• August

• 2023

FDA approves first therapeutic indication for Daxxify for injection for the treatment of cervical dystonia

LEARN MORE